For adolescent medicine pediatricians at IU School of Medicine, scientific inquiry underpins all activities –from clinical care and teaching to empiric research. This group of pediatric specialists understands that the most impactful research related to adolescent health is interdisciplinary and collaborative within and across disciplines, departments and universities; and research must engage the community as a partner. Research projects here have led to important policy changes that impact the health of communities.

This productive approach to medical research enables the adolescent medicine team to recruit top-notch faculty who are excellent clinicians, teachers and investigators. Adolescent medicine faculty are nationally known for research in adolescent health as well as for advocacy and policy issues related to adolescents on the regional and national levels. The team’s research portfolio has grown from a $35,000 award to Donald Orr, MD, in 1984 to approximately $3 million annually.

HPV Research

The IU School of Medicine Center for HPV Research focuses on improving the understanding of Human Papillomavirus (HPV) transmission and infection, and prevention of HPV infection and its consequences.  Under the leadership of Professors Gregory Zimet and Dennis Fortenberry of the Department of Pediatrics Section of Adolescent Medicine, the Center for HPV Research fosters cohesion and collaboration among investigators pursuing HPV-related research. This group of scholars represents a growing synergy between the disciplines of medicine, health marketing, psychology, and public health to establish a world-class center for HPV research, research training, and research translation.

Active Studies

The Section of Adolescent Medicine at IU School of Medicine performs a wide variety of research projects encompassing multiple pediatric specialty areas. Research investigators in this group are CITI (Collaborative Institutional Training Initiative) certified and uphold the standards of Good Clinical Practices. Along with the Principal Investigators, adolescent medicine researchers continue to ask new questions and turn that knowledge into useful practices that can be translated to patients and policy-makers. Participant study requirements are available through CTSI.

Study of Pilot Manufacturing Lot of HPV 16 Virus-Like Particle (VLP) Vaccine in the Prevention of HPV infection in 26- to 45-Year-Old-Women

A Placebo-Controlled, Dose Ranging Study of Quadrivalent HPV Virus-Like Particle (VLP) Vaccine in 16- to 23-Year-Old-Women

An investigation of provider-parent-son decision-making about HPV vaccination and preliminary test of the effects of educational messaging on the intent to vaccinate sons

A Study to Evaluate the Efficacy of Quadrivalent HPV (Types 6, 11, 16,  and 18) L1 Virus Like Particle (VLP) in Reducing the Incidence of HPV 6-, 11-, 16-, and 18- Related Genital Infections